Biologics target and suppress specific drivers of inflammation and work well in some patients to treat the symptoms of nasal polyposis.
Analysis of Five-Year Recurrence Patterns in Sinonasal Cancer
Sinonasal cancer shows an 11.7% recurrence rate after a five-year disease- free period, but varies by tumor pathology.
BSS Should Be Considered in Differential Diagnosis
A look at the imaging characteristics and clinical outcomes of biphenotypic sinonasal sarcoma (BSS)?
Is Acupuncture Effective in Reducing Overall Symptomatology in Chronic Rhinosinusitis?
There is insufficient evidence to support the use of acupuncture in CRS.
Reboot Approach Significantly Reduces Post-Op Nasal Polyp Recurrence
The reboot approach significantly reduced nasal polyp recurrence for 30 months postoperatively compared to the current mucosa-sparing approach.
Biologics for Chronic Rhinosinusitis and Nasal Polyposis
Do Preoperative Corticosteroids Benefit Patients with Chronic Rhinosinusitis with Nasal Polyposis?
Multiple therapeutic options may be effective for treating mild pediatric OSA including observation, management with anti-inflammatory medications, and surgery.
Hierarchical Task Analysis Can Help Reduce Error in FESS
HTA and the Systematic Human Error Reduction and Prediction Approach (SHERPA) are valuable tools to highlight potential errors in functional endoscopic sinus surgery (FESS).
Sinus Surgery Improves Olfaction for About Half of Patients with CRS
Olfaction can be improved by sinus surgery in about every second chronic rhinosinusitis (CRS) patient.
Tranexamic Acid Could Decrease Operative Time, Intraoperative Blood Loss in ESS
A look at how effective systemic tranexamic acid is compared to a control in blood loss, operative time, and surgical field and incidence of postoperative emesis and thromboembolism in endoscopic sinus surgery (ESS).
- 1
- 2
- 3
- …
- 19
- Next Page »